Invention Grant
- Patent Title: Allogeneic tumor cell vaccination
- Patent Title (中): 同种异体肿瘤细胞接种
-
Application No.: US14081761Application Date: 2013-11-15
-
Publication No.: US09301998B2Publication Date: 2016-04-05
- Inventor: Tamar Peretz , Michal Lotem , Arthur Machlenkin , Shoshana Frankenburg , Inna Ben David , Anna Kuznetz , Yael Gelfand , Galit Eisenberg , Merav Darash Yahana
- Applicant: HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD..
- Applicant Address: IL Jerusalem
- Assignee: HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.
- Current Assignee: HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.
- Current Assignee Address: IL Jerusalem
- Agency: Vorys, Sater, Seymour & Pease LLP
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C12N5/09 ; C12Q1/68 ; G01N33/574
Abstract:
The present invention relates to cancer immunotherapy, specifically to allogeneic tumor cell vaccines. According to some embodiments, the invention provides novel cell lines useful as therapeutic cell vaccine compositions. The invention further provides advantageous screening methods and means for identifying patients amenable for treatment with partially Human Leukocyte Antigen (HLA) matched allogeneic cell vaccines. Therapeutic compositions and methods for use in proliferative disorders are further provided.
Public/Granted literature
- US20140141045A1 Allogeneic Tumor Cell Vaccination Public/Granted day:2014-05-22
Information query
